Free Trial
OTCMKTS:POLXF

Polydex Pharmaceuticals (POLXF) Stock Price, News & Analysis

Polydex Pharmaceuticals logo
$1.99 +0.01 (+0.30%)
As of 08/7/2023

About Polydex Pharmaceuticals Stock (OTCMKTS:POLXF)

Key Stats

Today's Range
$1.99
$1.99
50-Day Range
$1.99
$1.99
52-Week Range
$0.55
$2.01
Volume
2,000 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive POLXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Polydex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

POLXF Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Polydex Pharmaceuticals Ltd.
Polydex Pharmaceuticals GAAP EPS of -$0.09, revenue of $1.09M
Polydex Pharmaceuticals Ltd
See More Headlines

POLXF Stock Analysis - Frequently Asked Questions

Polydex Pharmaceuticals' stock was trading at $1.9860 on January 1st, 2025. Since then, POLXF shares have increased by 0.0% and is now trading at $1.9860.
View the best growth stocks for 2025 here
.

Shares of POLXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
7/03/2025
Fiscal Year End
1/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
N/A
Current Symbol
OTCMKTS:POLXF
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.41 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (OTCMKTS:POLXF) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners